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Abstract
Background: Spinal cord injury (SCI), including immediate mechanical injury and secondary injury, is associated with the
inflammatory response, apoptosis and oxidative stress in response to traumatic injury. Tanshinone IIA (TIIA) is one of the
major extracts obtained from Salvia miltiorrhiza BUNGE, which has anti-inflammatory and anti-apoptotic effects on many
diseases. However, little is known about the effects of TIIA treatment on SCI. Therefore, the aim of the present study is to
evaluate the pharmacological action of TIIA on secondary damage and the underlying mechanisms of experimental SCI in
rats.
Methodology/Principal Findings: SCI was generated using a weight drop device on the dorsal spinal cord via a two-level
T9-T11 laminectomy. SCI in rats resulted in severe trauma, characterized by locomotor disturbance, edema, neutrophil
infiltration, the production of astrocytes and inflammatory mediators, apoptosis and oxidative stress. TIIA treatment (20 mg/
kg, i.p.) after SCI induced significant effects: (1) improved motor function (Basso, Beattie and Bresnahan scores), (2) reduced
the degree of tissue injury (histological score), neutrophil infiltration (myeloperoxidase activity) and the expression of
astrocytes, (3) inhibited the activation of SCI-related pathways, such as NF-kB and MAPK signaling pathways, (4) decreased
the production of pro-inflammatory cytokines (TNF-a, IL-1b, and IL-6) and iNOS, (5) reduced apoptosis (TUNEL staining, and
Bcl-2 and caspase-3 expression) and (6) reversed the redox state imbalance.
Conclusions/Significance: The results clearly show that TIIA has a prominent protective effect against SCI through
inhibiting the inflammatory response and apoptosis in the spinal cord tissue after SCI.
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Introduction
Spinal cord injury (SCI) is a prevalent traumatic injury in the
central nervous system (CNS) that leads to motor and sensory
dysfunction in all ages. Trauma to the spinal cord causes
immediate mechanical damage and a cascade of secondary
damage [1]. After traumatic insult to the spinal cord, the tissues
exhibit a progressive morphologic change, such as ischemia,
hemorrhage, and edema [1,2]. The secondary damage to the
spinal cord develops within from minutes to hours following initial
mechanical damage, and leads to a cascade of extracellular and
intercellular events, including the infiltration of inflammatory cells,
the destruction of neuronal and glial cells, neuronal dysfunction
and death, and oxidative stress. Although great efforts have made
to improve the outcome of patients with SCI, advances in therapy
for this disease have been limited.
The pathophysiological mechanisms of SCI are complicated.
During this period, inflammatory reactions are a crucial process of
the secondary injury [3,4]. Proinflammatory cytokines, such as
TNF-a, IL-1b and IL-6, are primarily produced by inflammatory
cells, and exist widely at the site of the lesion [1,5]. Studies have
demonstrated that the activation of MAPK signaling pathways
following SCI is an important step in the inflammatory response
[6]. Moreover, NF-kB is a major transcription factor that
modulates the production of pro-inflammatory cytokines in the
CNS [7,8]. Previous studies have shown that apoptosis, which is
regulated primarily through the caspase and Bcl-2 families [9,10],
is an important event in the secondary injury after SCI [11].
Reports indicate that apoptosis is involved in secondary degener-
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the spinal cord below the injured area. In addition, oxidative
stress, which results in the imbalance of the redox state and
contributes to the development of SCI. Because of the complex
pathogenesis of SCI, a therapy that has multiple targets will be
effective.
Tanshinone IIA (TIIA) is an important lipophilic diterpene
extracted from Salvia miltiorrhiza BUNGE and is used in Chinese
traditional herbal medicine (Danshen) for the treatment of many
diseases, such as cardiovascular [12,13], cerebrovascular [14,15]
and postmenopausal syndromes [16]. Previous studies show that
TIIA might exert a series of biochemical effects through its anti-
inflammatory [12,16–18], anti-oxidative [19] and anti-apoptotic
properties [20], and has been used to prevent ischemic injury [21].
However, whether TIIA produces protective effects to alleviate
traumatic injury in the spinal cord is not yet clear.
In the present study, we aim to evaluate effects of TIIA on
traumatic SCI. We used a weight drop device (NYU impactor) to
create a rat SCI model to investigate a series of changes that occur
in the spinal cord and to analyze the protective effects of TIIA. In
our research, we found that pro-inflammatory factors were up-
regulated after SCI, and subsequently the apoptosis process was
activated. Moreover, our results demonstrated that TIIA markedly
inhibited the expression of pro-inflammatory factors and related
pathways, ameliorated the activation of apoptosis, and reversed
the imbalance of the redox state.
Materials and Methods
Animal preparation
Sprague-Dawley male adult rats, weighing 220–250 g each,
were obtained from the Animal Center (Fourth Military Medical
University, Xi’an, China). The rats were kept in a temperature-
controlled house under a 12 h light/dark cycle and fed a standard
laboratory diet and water ad libitum. The Animal Care and Use
Committee of the Fourth Military Medical University approved all
experiments in accordance with the Declaration of the National
Institutes of Health Guide for Care and Use of Laboratory
Animals (Publication No. 85-23, revised 1985).
Spinal cord injury
Spinal cord injury was induced using a weight drop device as
previously reported [22]. Before this surgical operation, all
instruments were autoclaved for sterilization. The acclimatization
of rats was achieved in the surgical room prior to the start of the
experiments. All animals were anaesthetized through intraperito-
neal injection of 4% sodium pentobarbital (40 mg/kg, i.p.). An
incision was made along the middle of the back, exposing the
paravertebral muscles. A laminectomy was performed at the T9–
T11 level, exposing the cord without damaging the dura. The
exposed dorsal surface of the cord was subjected to weight drop
impact using a 10-g metal rod at a height of 25 mm. Subsequently,
the lesioned muscle and skin were sutured in layers, followed by a
1.0 ml subcutaneous injection of saline solution to replace the
blood volume lost during the surgery. After the surgical operation,
sterile gauze was wrapped around the wound. Animals were
injected with penicillin (intramuscularly, 100,000 unit/per ani-
mal/day) to prevent post-operative infection. To relieve the pain
from surgery, we subcutaneously injected buprenorphine
(0.03 mg/kg) post-surgery for 3 days. During recovery from
anesthesia, the rats were placed in a room with moderate
temperature and humidity and covered with a warm blanket. A
standard diet and water were provided daily to the rats ad libitum.
Manual bladder expression was performed twice a day until the
rats were able to urinate by themselves. Throughout the process,
symptoms of infection, pain, decubitus, dehydration and autopha-
gia were monitored daily.
Experimental design
Rats were randomly divided into four groups, namely the sham
group, sham/TIIA group, SCI group and SCI/TIIA group. We
injected a 0.9% sterile saline (0.09 g NaCl dissolve 100 ml distill
water) solution as a vehicle control. In the sham group, the animals
were only subjected to laminectomy. In the sham/TIIA group, the
animals were subjected to laminectomy with TIIA treatment. In
the SCI group, the animals were subjected to SCI using an
impactor and treated with an intraperitoneal injection of TIIA.
TIIA was administered 1 h before operation (50 mg/kg). From
day 1 to 7 post-SCI, TIIA was administrated (20 mg/kg) once a
day at the same time. The current dose and timing of TIIA
administration were applied on the basis of our preliminary
experiments. At the indicated time point, the rats were sacrificed
using cervical dislocation in all groups. Subsequently, the spinal
cord was immediately exposed from T1 to T12, and the damaged
tissue (T9 to T10) at the site of injury was cut. The time of sacrifice
was determined according to the different parameters measured:
motor function (BBB) score=10 days after SCI; TUNEL
staining=3 days after SCI; western blot analysis for caspase-3
and Bcl-2=1, 3 and 7 days after SCI; real-time PCR analysis of
proinflammatory cytokines=6 h after SCI; and other measur-
ements=24 h after SCI.
Behavioral examination
A motor function recovery test (n=6) was performed twice a
day from Day 1 to Day 10 after the spinal cord was contused. The
behavioral test was scored in accordance with the rules of Basso,
Beattie and Bresnahan (BBB) [28], which comprise 21 criteria for
the movement of lower limbs, from complete paralysis to complete
mobility. These criteria are based on the accurate observation of
the lower limbs, including movement, step, and coordinated motor
action. Two additional investigators blinded to treatment and
grade observed the mechanically contused animals.
Hematoxylin-eosin staining
The animals were sacrificed at 24 h after injury (n=4 for each
group) in all groups. Briefly, the rats were intracardially perfused
with saline followed by treatment with ice-cold 4% paraformal-
dehyde. Subsequently, the spinal cord, including the center site of
injury tissue, was collected. After fixation, the tissue blocks were
embedded in paraffin, and divided into 5-mm slices. Microscopic
evaluation was performed (Department of Pathology, Xijing
Figure 1. Effects of TIIA on functional recovery after SCI. The
function of hindlimb recovery was accessed from day 1 to day 10 after
SCI by Basso, Beattie and Bresnahan scores. The hindlimb dysfunction
was ameliorated with treatment of TIIA (20 mg/kg). Bars represent
means 6 SEM. *p,0.05 vs. SCI group.
doi:10.1371/journal.pone.0038381.g001
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the slices were scored for edema, neutrophil infiltration, and
hemorrhage. A scale of 0–4 represents the severity of spinal cord
injury: 0 for none or minor, 1 for modest or limited, 2 for
intermediate, 3 for widespread or prominent, and 4 for widespread
and most prominent [26]. These tasks were conducted in a blinded
manner, so that investigators were not able to identify the
treatment and outcome of the animal until the completion of the
measurement.
Myeloperoxidase activity assay
The myeloperoxidase (MPO) activity, an indicator of polymor-
phonuclear leukocyte accumulation, was determined in the spinal
cord tissue as previously described [27]. The extracted injured
tissues from rats of all groups (n=4 for each group) were weighed
at 24 h after SCI, and the myeloperoxidase activity was measured.
Each tissue sample was homogenized in homogenate medium
[0.5% (w/v) hexadecyltrimethyl-ammonium bromide dissolved in
10 mM potassium phosphate buffer (pH 7)] and centrifuged at
20,0006g for 30 min at 4uC. An aliquot of the supernatant was
subsequently incubated with a solution of 1.6 mM tetramethyl-
Figure 2. Effects of TIIA on histological changes at 24 h after SCI. Normal structure of spinal cord was observed in the sham (A) and sham/
TIIA (B) groups at 24 h after SCI. A significant damage of spinal cord was shown by the presence of edema, haemorrhage and loose structure tissue at
24 h after SCI (C). A significant protective effect of TIIA (20 mg/kg) was observed in the SCI/TIIA group (D). wm: white matter; gm: gray matter. The
histological score was accessed in a blinded manner (E). MPO activity in tissues was significantly increased at 24 h in the SCI group compared with the
sham and sham/TIIA groups and was decreased with the treatment of TIIA (F). Bars represent means 6 SEM. **p,0.001 vs. sham group,
#p,0.05 vs.
SCI group.
doi:10.1371/journal.pone.0038381.g002
Figure 3. Effects of TIIA on the activation of astrocytes at 24 h after SCI. Few positive staining cells for GFAP were observed in the spinal
cord tissues collected from the sham (A) and sham/TIIA (B) groups. A significant increase of GFAP positive cells was found in tissue from the SCI group
at 24 h after injury (C). A significant reduction of GFAP positive cells was observed in the SCI/TIIA group (D). Analysis of the amount of GFAP showed
the similar results (E). Bars represent means 6 SEM. **p,0.001 vs. sham group,
# p,0.05 vs. SCI group.
doi:10.1371/journal.pone.0038381.g003
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absorbance was measured spectrophotometrically at 460 nm. The
MPO activity was defined as the quantity of enzyme required to
degrade 1 mmol of H2O2 per min at 37uC, expressed as units of
MPO/g wet tissue.
Immunohistochemistry
Animals were sacrificed at 24 h after injury (n=4 for each
group) in all groups. Subsequently, tissue blocks were cut into 5-
mm slices as mentioned above. After dewaxing and hydration, the
tissue slices were incubated with citrate buffer (10 mM citric acid,
0.05% Tween 20, pH 6.0) for 10 min at 121uC to facilitate GFAP
antigen retrieval. The sections were incubated in 1% H2O2 for
30 min at room temperature to inhibit endogenous peroxidase
activity. After washing in PBS, the sections were preincubated with
goat serum albumin for 30 min at 37uC followed by an incubation
with a primary antibody against GFAP (Millipore, Bedford, MA,
USA) for 18 h at 4uC. Subsequently, the sections were washed
with PBS and stained with biotin-labeled rabbit anti-mouse IgG
for 30 min at 37uC. The slices were washed with PBS and
incubated in horseradish peroxidase-labeled streptavidin working
solution for 30 min at 37uC. Finally, the slides were washed with
PBS before application of diaminobenzidine (DAB), covered with
a coverslip and analyzed under a light microscope.
TUNEL staining
The rats were anesthetized with an intraperitoneal injection of
4% sodium pentobarbital (40 mg/kg) in all groups (n=4 for each
group) on Day 3 after SCI. The paraffin-embedded tissue slices
were dewaxed, washed with PBS, and digested with proteinase K
in a wet box for 30 min at 37uC. After washing with PBS, the
slides were dipped in TUNEL reaction mixture, and incubated for
1 h at 37uC. After washing, the sections were incubated with
converter-AP for 30 min at 37uC, and washed with PBS.
Subsequently, the sections were stained with NBT/BCIP substrate
solution for 1 h, and the signals were observed under a
microscope. The cells with purple nuclei were considered dead.
The number of TUNEL positive cells was counted.
Extraction of RNA and Quantitative Real-time PCR
The rats were anesthetized with an intraperitoneal injection of
4% sodium pentobarbital (40 mg/kg) in all groups (n=4 for each
group) at 6 h after SCI. The lesioned tissue was dissected and
homogenized in a solution of TRIZOL reagent (Invitrogen,
Carlsbad, CA, USA). The RNA extraction was performed
according to the manufacturer’s instructions. The total RNA
concentration was determined spectrophotometrically. A total of
1 mg of RNA was incubated with a reverse transcription mixture at
42uC for 50 min, followed by PCR amplification with the specific
primers (synthesized by Invitrogen). We used the following
primers: for TNF-a,P 15 9-TGATCGGTCCCAACAAGGA -39
and P2 59- TGCTTGGTGGTTTGCTACGA -39; for IL-1b,P 1
59- TGCTGATGTACCAGTTGGGG -39 and P2 59-CTCCAT-
GAGCTTTGTACAAG -39; for IL-6, P1 59- GCCCTTCAG-
GAACAGCTATG -39 and P2 59- CAGAATTGCCATTGCA-
CAAC -39; for iNOS, P1 59- GCAAGT CCA
Figure 4. Effects of TIIA on NF-kB activation at 24 h after SCI. A
basal expression of p-NF-kB and total NF-kB were detected by Western
blot in the sham and sham/TIIA groups at 24 h after SCI, whereas NF-kB
levels were increased after SCI. Treatment of TIIA (20 mg/kg) reduced
the expression of NF-kB (A). The relative content of two types of NF-kB
was counted (B). Bars represent means 6 SEM. *p,0.05, **p,0.001 vs.
sham group;
#p,0.05 vs. SCI group.
doi:10.1371/journal.pone.0038381.g004
Figure 5. Effects of TIIA on MAPK pathway at 24 h after SCI. The
expression of p-p38 was up-regulated in the SCI group compared with
the sham and sham/TIIA groups. The level of p-p38 was attenuated with
TIIA treatment as compared to the SCI group (A). The analyzed data for
p-p38 are shown (B). The content of p-ERK was significantly increased in
the SCI group at 24 h compared with the sham and sham/TIIA groups.
TIIA prevented the expression of p-ERK (C). The analyzed data for p-ERK
are shown (D). p-JNK was up-regulated after SCI, but a significant
reduction of p-JNK in the tissues from the SCI/TIIA group was observed
(E). The analyzed data for p-JNK are shown (F). Bars represent means 6
SEM. **p,0.001 vs. sham group,
#p,0.05 vs. SCI group.
doi:10.1371/journal.pone.0038381.g005
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CAATGGCAT G-39; for GAPDH, P1 59- CCCCCAATG-
TATCCGTTGTG -39 and P2 59-TAGCCCAGGATGCCCTT-
TAGT -39. The PCR conditions were 95uC for 15 s followed by
30 cycles of amplification consisting of 95uC for 5 s and 60uC for
30 s. The reactions were performed in triplicate, and the results
were averaged. Each value was normalized to GAPDH mRNA
levels to control for variations in the amount of input cDNA. The
relative expression level of the genes compared with the control
group was calculated using the DDCt method.
Extraction of protein and western blot
The tissues (n=4 for each group) were homogenized in lysis
buffer (10 mM Tris-HCl, 250 mM sucrose, 5 mM MgCl2,2m M
EGTA, 1 mM phenylmethylsulfonyl fluoride, 2 mM sodium
orthovanadate, 1 mM NaF, 1 mM leupeptin, 2 mM pepstatin
A, 1 mM dithiothreitol)) and centrifuged at 4uC for 15 min at
900 g. Subsequently, the supernatant (total protein) was collected
and the protein levels were quantified using a Coomassie brilliant
blue assay. Total protein (50 mg) was separated on 12% SDS-
polyacrylamide gels and transferred to nitrocellulose filter mem-
branes. The membranes were labeled with primary antibodies
(Millipore, Bedford, MA, USA) for phosphorylated or total NF-kB
(1:1000) and MAPKs (p38, ERK and JNK) (1:1000), iNOS
(inducible Nitric Oxide Synthase) (1:400), caspase-3 (1:200), Bcl-2
(1:200), and b-actin (1:5000) overnight at 4uC. The membranes
were incubated with the appropriate horseradish peroxidase-
coupled secondary antibodies (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, USA) diluted at 1:5000 for 1 h at 37uC followed
by enhanced chemiluminescence detection of the proteins using an
ECL kit (BestBio Inc, Shanghai, China). The protein density was
quantified using imaging software (BioSens Digital Imaging 5,
Shanghai Bio-Tech Inc, Shanghai, China). For the western blot
analysis, caspase-3 and Bcl-2 were measured at 1, 3 and 7 days
after SCI, and the other proteins were measured at 24 h after SCI.
Biochemical analysis
To determine the cytokine levels (n=4 for each group), the
lesion site was rapidly dissected and homogenized in PBS at 24 h
after SCI. After centrifugation at 4uC for 15 min at 900 g, the
supernatants were used to measure the concentrations of TNF-a,
IL-1b and IL-6 using corresponding ELISA kits (R&D systems,
Minneapolis, MN), and the levels of malondialdehyde (MDA) and
superoxide dismutase (SOD) using corresponding kits (Jiancheng
Bioengineering Institute, Nanjing, China). The data are presented
as the mean 6 SEM from three replicate experiments.
Statistical analysis
The data are expressed as the mean 6 SEM, and the statistical
analysis was performed with two-way analysis of variance
(ANOVA) using the SPSS 13.0 software package (SPSS Inc.,
Chicago, IL), in which surgery (SCI vs. sham) and treatment (TIIA
vs. vehicle) were the two fixed factors. A post-hoc analysis was
performed using Dunnett’s test for multiple comparisons. A
significant difference was accepted as significant if p,0.05.
Results
Effects of TIIA on functional recovery after SCI
The hindlimb movements were abolished immediately after
SCI. A spontaneous functional recovery after SCI in all groups
was observed. As shown in Fig. 1, the rats in the SCI group
gradually improved from Day 3, and rats in the SCI/TIIA group
improved more rapidly. The statistical analysis showed a
significantly greater increase in the BBB score from Day 3 to
Day 10 in the SCI/TIIA group than in the SCI group. Ten days
after SCI, the BBB average scores were 2.860.6 and 660.8 in the
SCI and the SCI/TIIA groups, respectively (Fig. 1, p,0.05),
indicating that TIIA treatment could promote the movement of
rats with SCI.
Figure 6. Effects of TIIA on the expression of pro-inflammatory cytokines at 6 h after SCI. The mRNA expression of TNF-a, IL-1b and IL-6
was enhanced in the tissues from the SCI group, but treatment of TIIA reduced their mRNA expression (A–C). Compared to the sham and sham/TIIA
groups, the protein level of TNF-a, IL-1b and IL-6 was significantly up-regulated, whereas TIIA reduced the level of these proteins (D–F). Bars represent
means 6 SEM. *p,0.05, **p,0.001 vs. sham group;
#p,0.05 vs. SCI group.
doi:10.1371/journal.pone.0038381.g006
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To evaluate the protective effect of TIIA on SCI, we observed
histological changes in the spinal cord using electronic light
microscopy at 24 h after operation. There were normal structures
in both the white and grey matter in the sham and the sham/TIIA
groups (Fig. 2A and 2B). The weight-drop rod was used to
generate a mechanical insult, including edema, hemorrhage,
neutrophil infiltration and loosened tissue structure in the SCI
group (Fig. 2C). Compared with the SCI group, the morphologic
changes were significantly alleviated in the TIIA-treated group
(Fig. 2D), and some areas of the spinal cord even exhibited normal
histological features. The calculated SCI scores are shown in
Fig. 2E. TIIA exhibited a significant protective effect against SCI.
Effects of TIIA on neutrophil infiltration after SCI
As previously described, the histological changes of SCI were
associated with the influx of leukocytes into the spinal cord.
Therefore, we studied the effect of TIIA on neutrophil infiltration
using an MPO activity assay at 24 h after SCI. The results showed
no significant difference in MPO activity between the sham and
sham/TIIA groups (Fig. 2F), but the MPO activity was increased
in the SCI group. On the contrary, the MPO activity was
markedly decreased in the SCI/TIIA group (Fig. 2F).
Effects of TIIA on the activation of astrocytes after SCI
To test whether the activation of astrocytes in the injured tissues
was changed, we measured GFAP positive cells under electronic
light microscopy at 24 h after SCI. In both the sham and sham/
TIIA groups, few GFAP positive cells were stained with GFAP
antibody (Fig. 3A and 3B). The sections from the SCI group
exhibited a significant increase in positive staining for astrocytes
(Fig. 3C). However, as shown in Fig. 3D, TIIA treatment reduced
the amount of GFAP-positive cells. The number of GFAP-positive
cells was calculated in Fig. 3E.
Effects of TIIA on NF-kB activation after SCI
As the NF-kB pathway plays a key role in inflammation-related
injury, we investigated the level of phosphorylated NF-kB (p-NF-
kB) and total NF-kB using western blot analysis to assess the
therapeutic effect of TIIA at 24 h after SCI (Fig. 4A and 4B). In
the sham and sham/TIIA groups, we detected a basal level of p-
NF-kB and total NF-kB. The p-NF-kB was significantly increased
and the total NF-kB was up-regulated in rats that were subjected
to SCI. Moreover, we found that the expression of both forms of
NF-kB was reduced in the SCI/TIIA group. As a result, we
concluded that TIIA could inhibit the activation of the NF-kB
pathway after SCI.
Effects of TIIA on the activation of MAPK (p38, ERK, JNK)
pathway after SCI
Our study also measured the expression of p38, ERK and JNK
in spinal cord tissue to fully investigate the mechanisms involved in
the TIIA-mediated protective effects against SCI. The result
showed that there were no differences in the activation of those
pathways between the sham and sham/SCI groups at 24 h after
operation (Fig. 5A and F). There was more p-p38 in the lesion site
from the SCI group, but the up-regulation of p-p38 was
significantly attenuated upon TIIA treatment (Fig. 5A and 5B).
The changes in p-ERK and p-JNK expression were similar to that
of p-p38 (Fig. 5C to 5F). Collectively, these data showed that TIIA
could attenuate the activation of MAPK pathway after SCI.
Effects of TIIA on the expression of pro-inflammatory
cytokines after SCI
In our study, we evaluated the effect of TIIA on the expression
of pro-inflammatory cytokines, such as TNF-a, IL-1b, and IL-6.
In our preliminary experiment, we analyzed these cytokines at 6,
12 and 24 h after SCI. We found that the mRNA level of TNF-a,
IL-1b, and IL-6 peaked at 6 h, and the concentration of these pro-
inflammatory factors quickly decreased at 24 h after SCI (data not
shown). Therefore, in this study, we measured the mRNA and
protein expression of these cytokines from the damaged site at 6 h
after SCI. As shown in Fig. 6, there were low levels of these
cytokines in the sham and sham/TIIA groups. A significant
increase in the mRNA and protein expression of TNF-a, IL-1b,
and IL-6 was observed in the spinal cords of the SCI group (Fig. 6).
Furthermore, compared with the SCI group, treatment with TIIA
attenuated the expression of TNF-a, IL-1b, and IL-6 in the spinal
cord.
Figure 7. Effects of TIIA on the expression of iNOS at 24 h after
SCI. RT-PCR results demonstrated that the expression of iNOS was
increased after SCI. Treatment of TIIA decreased the mRNA level of iNOS
compared to the SCI group (A). Western blot analysis demonstrated that
the protein expression of iNOS was increased in the tissues from the SCI
group, but the treatment of TIIA significantly reduced the level of iNOS
(B). The analyzed data for relative iNOS protein content are shown (C).
Bars represent means 6 SEM. *p,0.05, **p,0.001 vs. sham group;
#p,0.05 vs. SCI group.
doi:10.1371/journal.pone.0038381.g007
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iNOS is another inflammation-related mediator. We evaluated
the expression of iNOS at 24 h after SCI. The results of the real-
time PCR analysis showed that SCI caused a significant increase
in iNOS mRNA expression in the SCI group (Fig. 7A). However,
this increase was markedly downregulated upon the intraperito-
neal injection of TIIA in the SCI/TIIA group (Fig. 7A). In
addition, the results of the western blot analysis indicated that the
SCI-induced iNOS protein expression was also decreased in the
SCI/TIIA group (Fig. 7B and C).
Effects of TIIA on apoptosis in spinal cord after SCI
To determine whether TIIA could affect SCI-induced apopto-
sis, we performed TUNEL staining on spinal cord sections. We
found that the highest amount of apoptotic cells occurred at Day 3
after SCI in our preliminary experiment, thus we chose to analyze
Figure 8. Effects of TIIA on apoptosis in spinal cord after SCI. Few apoptotic cells in the tissues from the sham and sham/TIIA groups were
observed (A–B). SCI induced a marked increase of apoptotic cells at 3 days after trauma (C). In contrast, tissues obtained from TIIA treatement group
showed significantly less apoptotic cells (D). The number of TUNEL positive cells was counted in 5 to 10 fields for each slide and the analyzed data are
shown (E). Bars represent means 6 SEM. **p,0.001 vs. sham group,
#p,0.05 vs. SCI group.
doi:10.1371/journal.pone.0038381.g008
Figure 9. Effects of TIIA on apoptosis-related factors after SCI. The protein expression of Bcl-2 was reduced in the SCI group at 1 day and 3
days compared to the sham and sham/TIIA groups, whereas Bcl-2 was up-regulated in the SCI/TIIA group (A). The analyzed data are shown. (B) The
cleaved caspase-3 expression began to increase at 1 day, peaked at 3 days and quickly reduced to a lower level at 7 days after SCI. However, TIIA
treatment decreased the cleaved caspase-3 (C). The analyzed data are shown (D). Bars represent means 6 SEM. *p,0.05 vs. sham group,
#p,0.05 vs.
SCI group.
doi:10.1371/journal.pone.0038381.g009
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few TUNEL-positive stained cells were detected in the two sham
groups (Fig. 8A and B). Moreover, SCI induced more TUNEL-
positive cells in the grey and white matter in the SCI group
(Fig. 8C), but TIIA resulted in a marked reduction in the number
of these cells compared with the SCI group (Fig. 8D). The results
of the quantitative analysis are shown in Fig. 8E. These data
suggest that TIIA could reduce SCI-induced cell apoptosis in the
spinal cord.
Effects of TIIA on apoptosis-related factors after SCI
To further confirm the effect of TIIA on apoptosis, we
measured two apoptosis-related factors. First, Bcl-2, an inhibitive
factor of apoptosis was subjected to western blot analysis. The
results showed that SCI resulted in a significant reduction in the
expression of Bcl-2 at Day 1 and Day 3 in the SCI group (Fig. 9A
and B). However, in the TIIA/SCI group, the level of Bcl-2 was
significantly increased compared with the SCI group (Fig. 9A and
B). No difference in Bcl-2 expression was observed at the site of
insult in the tissues on Day 7 after SCI (Fig. 9B). Second, we tested
the change in caspase-3 expression, which is a component of the
cysteine protease family that plays a key role in apoptosis.
Compared with the rats in the sham and sham/TIIA groups, SCI
induced a marked increase in caspase-3 at each time point (Fig. 9C
and D). In contrast, cleaved caspase-3 was attenuated at Day 3
and Day 7 in the SCI/TIIA group compared with the SCI group
(Fig. 9C and D).
Effects of TIIA on oxidative stress markers after SCI
SOD and MDA are anti-oxidant and a pro-oxidant markers of
oxidative stress, respectively, and were measured at 24 h after SCI.
In the SCI group, SCI caused a significant decrease in the SOD
activity and an increase in the MDA level. Compared with the SCI
group, TIIA treatment after SCI dramatically rescued the SOD
activity and significantly decreased the MDA level, indicating that
TIIA played an important anti-oxidative role after SCI (Fig. 10A
and B).
Discussion
In this study, we demonstrated that TIIA exhibited a protective
effect against SCI in rats. The administration of TIIA promoted
motor function recovery of the hind limbs, ameliorated histopath-
ological changes, inhibited the expression of proinflammatory
factors and NF-kB and MAPK pathways, regulated SCI-induced
apoptosis and apoptosis-related factors, and reduced the extent of
oxidative stress in rats subjected to mechanical compressive insult
by an NYU impactor.
To simulate the major events of SCI in rats, various
experimental models have been developed [20]. One of the most
widely used models is contusive injury. In this model, a rapid insult
through dropping a weight onto the exposed surface of the dorsal
spinal cord results in an immediate and transient contusion, which
generates the primary damage. This device stimulates various
levels of injury through correlative intensity weight, from moderate
to severe, and even to complete paraplegia. The model’s success is
measured by the degree of movement in the bilateral hind limbs; a
successful model occurs when the bilateral hind limbs have no
movement [23]. In our experiment, we used this model to assess
the therapeutic effect of TIIA on SCI.
Tanshinone (Danshen), is an herbal drug derived from the dried
root of Salvia miltiorrhiza Bunge, and has been used either alone
or in combination with other herbal materials to clinically prevent
or treat many diseases in China and other countries [12,21]. TIIA
is one of the key components of Danshen. Previous studies suggest
that TIIA might exhibit anti-inflammatory, anti-apoptotic and
anti-oxidative capacities. We also assessed the therapeutic effects of
TIIA in the SCI model. Based on the BBB score, TIIA promoted
the recovery of locomotor function. Several studies demonstrate
evidence of edema, hyperemia and incompact structures in the
injured tissue [24]. We also observed the same results in the rat
model of SCI, and found a significant effect of TIIA against SCI.
Astrocytes are activated upon SCI and are involved in the
formation of a glial scar. Astrocytes also inhibit regeneration in the
CNS. Moreover, activated astrocytes increase the production of
intermediate filaments, such as GFAP (glial fibrillary acidic
protein) and can secrete other molecules to restrict axonal growth.
Together, this evidence showed that activated astrocytes exhibit a
detrimental effect upon SCI [25]. Our data showed that GFAP-
positive cells were increased after SCI, and TIIA administration
significantly reduced the number of these positive cells. As a result,
we conclude that TIIA effectively attenuated the number of
activated astrocytes and glial scar formation.
Pro-inflammatory cytokines, such as TNF-a, IL-1b and IL-6,
are key mediators and participate in the development of SCI
[26,27]. Nitric oxide (NO), which is mainly regulated through
iNOS, also contributes to secondary damage after SCI [28].
Moreover, there are several pathways to modulate these inflam-
matory factors, such as NF-kB and MAPKs pathways [29–31].
Consistent with other studies [32–36], we detected increased
mRNA and protein levels of pro-inflammatory cytokines and the
activation of inflammation related pathways in SCI-induced
Figure 10. Effects of TIIA on oxidative stress markers after SCI.
SCI induced the decrease of SOD activity at 24 h after SCI, but
treatment with TIIA increased SOD 65 activity (A). The MDA level was
significantly increased in the tissues from the SCI group at 24 h after
SCI. TIIA treatment inhibited SCI-induced increase in MDA level (B). Bars
represent means 6 SEM. **p,0.001 vs. sham group,
#p,0.05 vs. SCI
group.
doi:10.1371/journal.pone.0038381.g010
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reduced the levels of TNF-a, IL-1b, IL-6 and iNOS and markedly
inhibited the activation of NF-kB and MAPKs pathways in the
SCI model.
After injury, cell death occurs, and positive apoptotic cells are
found at the lesion area, especially in the white matter [37]. Bcl-2
family proteins play an important role in mediating the intrinsic
apoptotic pathway. Bcl-2 is an anti-apoptosis membrane protein,
and prevents cell apoptotic processes through the inhibition of
cytochrome c release from the mitochondria following the
activation of caspase [38]. Caspases are a family of proteases that
initiate apoptosis. Caspase-3 is a key factor in apoptosis. Various
stimulators, such as Bcl-2 and Bax, regulate caspase activation
[10,39]. Caspase-3 participates in the downstream functions of the
mitochondrial pathway, and the activation of caspase-3 might
result in irreversible apoptosis. We found that cleaved caspase-3
was over-expressed in the SCI group, and TIIA could alleviate the
effects of caspase-3. In addition, we found that treatment with
TIIA increased Bcl-2 expression in our animal SCI model,
suggesting that protection against apoptosis might be a prerequi-
site for regenerative processes in SCI.
Oxidative stress after SCI plays a pivotal role in secondary
damage, and contributes to tissue injury during a post-traumatic
inflammatory response and cell death [39]. During this process,
the balance between anti-oxidants and pro-oxidants is disrupted.
For example, SOD, which is a scavenger for reactive oxygen
species (ROS), is consumed during oxidative stress. However,
MDA, a lipid peroxidation end product, is increased during stress.
Consistent with previous studies [40], we showed that SCI induced
an increase in the expression of oxidative stress markers and
reduced the expression of anti-oxidant markers. We also showed
that TIIA treatment after SCI significantly reversed the changes of
SOD activity and MDA levels, thereby restoring the balance of the
redox state.
Taken together, we demonstrated that TIIA confers neuronal
protection against apoptosis and attenuates the inflammatory and
oxidative stress response after SCI. These data suggest that
combination therapy against multiple targets might promote
recovery from traumatic injury in the spinal cord. Although the
mechanisms involved in TIIA protection against SCI in rats
requires further elucidation, our data suggest that the application
of TIIA might be an effective treatment for SCI and that TIIA
could be widely used to alleviate SCI in humans in the future.
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